Clinical trial
Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand
NCT00398684 · Institut de Recherche pour le Developpement, Other · Completed
Key facts
| NCT number | NCT00398684 |
|---|---|
| Title | Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand |
| Lead sponsor | Institut de Recherche pour le Developpement, Other |
| Collaborators | Harvard School of Public Health (HSPH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH ANRS, Emerging Infectious Diseases |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Pregnancy |
| Intervention type | Drug |
| Interventions | Single dose nevirapine to the mother and to the child, Single dose nevirapine to the mother and placebo to the child, Single dose placebo to the mother and to the child |
| Enrollment | 1,792 |
| Start date | Jan 1, 2001 |
| Completion | Jun 1, 2004 |
| First posted | Nov 14, 2006 |
| Last update posted | May 7, 2008 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: